Description: The investment seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics Index ("underlying index"). The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
Category: Health
| Asset Allocation | |||
|---|---|---|---|
| Asset Class | Long % | Short % | Net Assets |
| Stock US | 89.59 | 0.00 | 89.59 |
| Stock non-US | 10.34 | 0.00 | 10.34 |
| Cash | 0.07 | 0.00 | 0.07 |
| Sector Weights | ||
|---|---|---|
| Sector | Equity % | Relative to Category |
| Healthcare | 100.00 | 99.57 |
| World Regions | ||
|---|---|---|
| Region | Equity % | Relative to Category |
| North America | 89.65 | 92.60 |
| Europe Developed | 9.36 | 4.28 |
| Japan | 0.99 | 0.54 |
| Australasia | 0.00 | 0.11 |
| Asia Emerging | 0.00 | 0.82 |
| United Kingdom | 0.00 | 1.65 |
| Africa/Middle East | 0.00 | 0.02 |